{
    "2020-12-22": [
        [
            {
                "time": "",
                "original_text": "医药生物行业报告：医保谈判落地不确定性消除 加大医药优质赛道关注度",
                "features": {
                    "keywords": [
                        "医药生物",
                        "医保谈判",
                        "不确定性消除",
                        "优质赛道"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：“三重行业红利 五重公司催化”助推智飞生物 强调Q1医药躁动机会",
                "features": {
                    "keywords": [
                        "医药生物",
                        "三重行业红利",
                        "五重公司催化",
                        "智飞生物",
                        "Q1躁动机会"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}